D'Andrea, Alan D <br/><br/>
The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)   
 - 290-2 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1538-4101 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>BRCA1 Protein--genetics<br/>Cell Nucleus--metabolism<br/>Chromosomal Instability--physiology<br/>Cisplatin--pharmacology<br/>DNA Methylation--drug effects<br/>DNA Repair--physiology<br/>Fanconi Anemia--drug therapy<br/>Fanconi Anemia Complementation Group F Protein<br/>Female<br/>Histone Acetyltransferases<br/>Histone Chaperones<br/>Humans<br/>Nuclear Proteins--genetics<br/>Ovarian Neoplasms--drug therapy<br/>RNA-Binding Proteins--genetics<br/>Signal Transduction--drug effects